siRNA, Anti-TFCP2L1, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT76841WQ-2OMe)

The product SIRGT76841WQ-2OMe is a type of small interfering RNA (siRNA) that targets TFCP2L1 gene and regulates the expression of gene. The siRNA interferes with the expression of TFCP2L1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_014553.2
Alternative Names CRTR1; LBP-9; LBP9
Related Diseases Fraser Syndrome 1
Purification HPLC
Target Gene
Gene ID 29842
Uniprot ID Q9NZI6
Sub Cat Target Species Modification Scale  
SIRGT77841WQ-2F TFCP2L1 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT78841WQ-2MOE TFCP2L1 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT79841WQ-LNA TFCP2L1 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT76841WQ-RB TFCP2L1 Human Ribo-modified Inquiry
SIRGT77841WQ-BB TFCP2L1 Human Backbone-modified Inquiry

Related Products